A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia

NCT01651273 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: BMS-852927
DRUG: BMS-852927
DRUG: BMS-852927
DRUG: Placebo

Sponsor

Bristol-Myers Squibb